tagitanlimab   Click here for help

GtoPdb Ligand ID: 13795

Synonyms: A-167 | Cotelet® | HBM-9167 | KL-A167 | KLA167
Approved drug Immunopharmacology Ligand
tagitanlimab is an approved drug
Compound class: Antibody
Comment: Tagitanlimab (KL-A167) is a humanized anti-programmed cell death-ligand 1 (PD-L1) monoclonal antibody [1]. It is designed to block the inhibitory PD-1/PD-L1 immune checkpoint and restore anti-tumour immunity.
Classification Click here for help
Compound class Antibody
Approved drug? Yes. China NMPA (2024)
International Nonproprietary Names Click here for help
INN number INN
11843 tagitanlimab
Synonyms Click here for help
A-167 | Cotelet® | HBM-9167 | KL-A167 | KLA167
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1206
Other databases
GtoPdb PubChem SID 507750428
Search PubMed clinical trials tagitanlimab
Search PubMed titles tagitanlimab
Search PubMed titles/abstracts tagitanlimab